SK Biopharmaceuticals Co., Ltd. (KRX:326030)

SK Biopharmaceuticals Statistics

Total Valuation

KRX:326030 has a market cap or net worth of KRW 7.64 trillion. The enterprise value is 7.52 trillion.

Market Cap	7.64T
Enterprise Value	7.52T

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:326030 has 78.31 million shares outstanding.

Current Share Class	78.31M
Shares Outstanding	78.31M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	12.88%
Float	28.06M

Valuation Ratios

The trailing PE ratio is 30.39 and the forward PE ratio is 45.30. KRX:326030's PEG ratio is 5.46.

PE Ratio	30.39
Forward PE	45.30
PS Ratio	13.21
PB Ratio	12.91
P/TBV Ratio	13.68
P/FCF Ratio	77.63
P/OCF Ratio	76.53
PEG Ratio	5.46

Enterprise Valuation

The stock's EV/EBITDA ratio is 75.79, with an EV/FCF ratio of 76.41.

EV / Earnings	29.92
EV / Sales	13.00
EV / EBITDA	75.79
EV / EBIT	92.25
EV / FCF	76.41

Financial Position

The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.21.

Current Ratio	1.84
Quick Ratio	1.34
Debt / Equity	0.21
Debt / EBITDA	0.96
Debt / FCF	1.27
Interest Coverage	10.22

Financial Efficiency

Return on equity (ROE) is 50.86% and return on invested capital (ROIC) is 11.07%.

Return on Equity (ROE)	50.86%
Return on Assets (ROA)	7.79%
Return on Invested Capital (ROIC)	11.07%
Return on Capital Employed (ROCE)	16.63%
Revenue Per Employee	2.40B
Profits Per Employee	1.04B
Employee Count	241
Asset Turnover	0.64
Inventory Turnover	0.37

Taxes

Income Tax	-151.72B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +19.16% in the last 52 weeks. The beta is 0.86, so KRX:326030's price volatility has been lower than the market average.

Beta (5Y)	0.86
52-Week Price Change	+19.16%
50-Day Moving Average	92,896.00
200-Day Moving Average	105,204.00
Relative Strength Index (RSI)	61.82
Average Volume (20 Days)	183,859

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:326030 had revenue of KRW 578.00 billion and earned 251.21 billion in profits. Earnings per share was 3,207.77.

Revenue	578.00B
Gross Profit	536.35B
Operating Income	111.72B
Pretax Income	85.17B
Net Income	251.21B
EBITDA	129.41B
EBIT	111.72B
Earnings Per Share (EPS)	3,207.77

Balance Sheet

The company has 268.69 billion in cash and 124.66 billion in debt, giving a net cash position of 144.03 billion or 1,839.21 per share.

Cash & Cash Equivalents	268.69B
Total Debt	124.66B
Net Cash	144.03B
Net Cash Per Share	1,839.21
Equity (Book Value)	591.47B
Book Value Per Share	7,246.94
Working Capital	276.72B

Cash Flow

In the last 12 months, operating cash flow was 99.77 billion and capital expenditures -1.41 billion, giving a free cash flow of 98.36 billion.

Operating Cash Flow	99.77B
Capital Expenditures	-1.41B
Free Cash Flow	98.36B
FCF Per Share	1,255.94

Margins

Gross margin is 92.79%, with operating and profit margins of 19.33% and 43.46%.

Gross Margin	92.79%
Operating Margin	19.33%
Pretax Margin	14.74%
Profit Margin	43.46%
EBITDA Margin	22.39%
EBIT Margin	19.33%
FCF Margin	17.02%

Dividends & Yields

KRX:326030 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	3.29%
FCF Yield	1.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KRX:326030 has an Altman Z-Score of 11.9 and a Piotroski F-Score of 6.

Altman Z-Score	11.9
Piotroski F-Score	6